Gain Therapeutics Ownership | Who Owns Gain Therapeutics?


OverviewForecastRevenueFinancialsChart

Gain Therapeutics Ownership Summary


Gain Therapeutics is owned by 8.64% institutional investors, 3.62% insiders, and 87.74% retail investors. Jones financial companies lllp is the largest institutional shareholder, holding 2.23% of GANX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.00% of its assets in Gain Therapeutics shares.

GANX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGain Therapeutics8.64%3.62%87.74%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jones financial companies lllp676.82K2.23%$1.21M
Dme capital management, lp566.13K1.87%$1.00M
Hohimer wealth management330.00K1.84%$422.40K
Vanguard group534.35K1.76%$945.80K
Geode capital management344.15K1.13%$609.19K
Cambridge investment research advisors318.64K1.05%$564.00K
Marshall wace, llp175.11K0.58%$309.94K
Morgan stanley155.68K0.51%$275.55K
Blackrock84.62K0.47%$108.31K
Ubs group140.68K0.46%$249.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hohimer wealth management330.00K0.10%$422.40K
Dme capital management, lp566.13K0.04%$1.00M
Benedict financial advisors35.00K0.01%$61.95K
Two sigma securities27.32K0.01%$48.36K
Virtu financial54.01K0.01%$96.00K
Xtx topco54.20K0.01%$95.94K
Prelude capital management35.82K0.00%$63.40K
Sandhill capital partners15.40K0.00%$27.26K
Bison wealth10.75K0.00%$19.78K
Cambridge investment research advisors318.64K0.00%$564.00K

Top Buyers

HolderShares% AssetsChange
Hohimer wealth management330.00K0.10%330.00K
Cambridge investment research advisors318.64K0.00%139.15K
Ubs group140.68K-108.04K
Morgan stanley155.68K-79.16K
Jane street group72.45K-72.45K

Top Sellers

HolderShares% AssetsChange
Timelo investment management---605.29K
Alyeska investment group---450.00K
Raymond james & associates---260.02K
Gotham asset management---245.90K
Cable car capital---145.00K

New Positions

HolderShares% AssetsChangeValue
Hohimer wealth management330.00K0.10%330.00K$422.40K
Jane street group72.45K-72.45K$128.24M
Xtx topco54.20K0.01%54.20K$95.94K
Susquehanna group, llp46.91K-46.91K$101.33K
Squarepoint ops38.54K0.00%38.54K$68.21K

Sold Out

HolderChange
Hm payson-1.00K
State of wyoming-1.19K
Citigroup-2.00K
Raymond james financial-2.30K
Citadel advisors-2.50K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202519-44.12%2,622,446-26.12%86.32%10-37.50%2-50.00%
Jun 30, 2025362.86%3,787,85934.77%1213.00%17-22.73%5150.00%
Mar 31, 20253529.63%2,384,40620.20%814.87%2116.67%350.00%
Dec 31, 202410-50.00%683,297-59.21%26.46%6-33.33%1-75.00%
Sep 30, 202420-25.93%1,675,173-44.84%62.21%9-50.00%4-20.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr360.55K1.00%-164.29K
Fidelity Extended Market Index152.75K0.42%7.25K
BANOR SICAV Rosemary S EUR Acc121.59K0.35%71.59K
iShares Micro-Cap ETF63.09K0.18%-
BlackRock Extended Equity Market K36.53K0.14%-16.00
Fidelity Total Market Index45.08K0.13%-96.00
Extended Equity Market Fund K35.44K0.12%-707.00
Fidelity Series Total Market Index38.58K0.11%-
Spartan Extended Market Index Pool F35.74K0.10%1.26K
NT Ext Equity Mkt Idx Fd - L29.48K0.10%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2024Mack Gene CFO and Interim CEOBuy$14.54K
Aug 09, 2024Islam Khalid Executive ChairmanBuy$49.94K
Jul 01, 2024RICHMAN ERIC I-Buy$14.52K
Jul 01, 2024RICHMAN ERIC I-Buy$6.15K
Mar 28, 2024Riley Jeffrey Scott-Buy$115.77K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q34-
2024 Q2--
2024 Q11-

GANX Ownership FAQ


Who Owns Gain Therapeutics?

Gain Therapeutics shareholders are primarily institutional investors at 8.64%, followed by 3.62% insiders and 87.74% retail investors. The average institutional ownership in Gain Therapeutics's industry, Biotech Stocks , is 45.24%, which Gain Therapeutics falls below.

Who owns the most shares of Gain Therapeutics?

Gain Therapeutics’s largest shareholders are Jones financial companies lllp (676.82K shares, 2.23%), Dme capital management, lp (566.13K shares, 1.87%), and Hohimer wealth management (330K shares, 1.84%). Together, they hold 5.93% of Gain Therapeutics’s total shares outstanding.

Does Blackrock own Gain Therapeutics?

Yes, BlackRock owns 0.47% of Gain Therapeutics, totaling 84.62K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 108.31K$. In the last quarter, BlackRock increased its holdings by 9.22K shares, a 12.23% change.

Who is Gain Therapeutics’s biggest shareholder by percentage of total assets invested?

Hohimer wealth management is Gain Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 330K Gain Therapeutics shares, valued at 422.4K$.

Who is the top mutual fund holder of Gain Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Gain Therapeutics shares, with 1.00% of its total shares outstanding invested in 360.55K Gain Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools